Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protoco (Q73806740)
scientific article published on 01 May 2000
Language:
(P31) (Q13442814)
(P304) 978-987
(P433) 5
(P478) 43
(P577) Monday, May 1, 2000
(P921) (Q244408)
(Q42824827)
(Q62736)
(P1433) (Q23929027)
(P1476) "Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group" (language: en)
(P2093) Cannon GW
Caldwell JR
Holt P
McLean B
Seidenberg B
Bolognese J
Ehrich E
Mukhopadhyay S
Daniels B
other details
description scientific article published on 01 May 2000

External Links